Orchestra BioMed Holdings, Inc. Stock
Equities
OBIO
US68572M1062
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.39 USD | -1.13% | -5.39% | -51.92% |
Financials (USD)
Sales 2024 * | 3.31M | Sales 2025 * | 3.9M | Capitalization | 157M |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | -55M | EV / Sales 2024 * | 47.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 40.3 x |
P/E ratio 2024 * |
-2.8
x | P/E ratio 2025 * |
-2.81
x | Employees | 56 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.03% |
1 day | -1.13% | ||
1 week | -5.39% | ||
Current month | -16.70% | ||
1 month | -16.54% | ||
3 months | -40.03% | ||
6 months | -2.44% | ||
Current year | -51.92% |
Managers | Title | Age | Since |
---|---|---|---|
Darren Sherman
FOU | Founder | 52 | 23-01-25 |
David Hochman
CEO | Chief Executive Officer | 49 | 23-01-25 |
Andrew Taylor
DFI | Director of Finance/CFO | 53 | 23-06-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rose
BRD | Director/Board Member | 73 | 23-01-25 |
Eric Fain
BRD | Director/Board Member | 63 | 23-01-25 |
David Hochman
CEO | Chief Executive Officer | 49 | 23-01-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.39 | -1.13% | 24,286 |
24-04-25 | 4.44 | -0.89% | 55,556 |
24-04-24 | 4.48 | -0.88% | 24,426 |
24-04-23 | 4.52 | +0.44% | 29,371 |
24-04-22 | 4.5 | -3.02% | 49,131 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.92% | 157M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- OBIO Stock